Grace Kong

Circulating tumour cells (CTCs) and PSMA PET correlates in the phase I PRINCE trial of 177Lu-PSMA-617 plus pembrolizumab for metastatic castration resistant prostate cancer (mCRPC).

Anis Hamid, Michael S Hofman, Mathias Bressel, Louise Emmett, Anthony M Joshua, Lavinia Anne Spain, Lisa Horvath, Megan Crumbaker, Anupama Pasam, Jason Callahan, Alisa Tubbs, Luisa Fernandez, Richard J Wenstrup, Grace Kong, Jeremy Howard Lewin, Ben Tran, Arun Azad, Joseph D Schonhoft, Rodney J Hicks, Shahneen Sandhu

Conference Proceedings  |  2022  |  Journal of Clinical Oncology

5027 Background: The Phase I PRINCE trial (NCT03658447) is evaluating the efficacy of 177Lu-PSMA-617 plus pembrolizumab for mCRPC..

Imaging of Neuroendocrine Neoplasms: Monitoring Treatment Response-AJR Expert Panel Narrative Review

Samuel J Galgano, Amir Iravani, Lisa Bodei, Ghassan El-Haddad, Michael S Hofman, Grace Kong

Journal article  |  2022  |  AMERICAN JOURNAL OF ROENTGENOLOGY

Neuroendocrine neoplasms (NENs) encompass a broad spectrum of tumors throughout the body and range in biologic behavior from indol..

Efficacy and Safety of Lu-177-DOTATATE in Lung Neuroendocrine Tumors: A Bicenter study

Lamiaa Zidan, Amir Iravani, Kira Oleinikov, Simona Ben-Haim, David J Gross, Amichay Meirovitz, Ophra Maimon, Tim Akhurst, Michael Michael, Rodney J Hicks, Simona Grozinsky-Glasberg, Grace Kong

Journal article  |  2022  |  JOURNAL OF NUCLEAR MEDICINE

The purpose of this study was to assess the efficacy and safety of 177Lu-DOTATATE in patients with somatostatin receptor (SSR)-pos..

Pivotal phase III COMPOSE trial will compare Lu-177-edotreotide with best standard of care for welldifferentiated aggressive grade 2 and grade 3 gastroenteropancreatic neuroendocrine tumors

Thorvardur Ragnar Halfdanarson, Diane Lauren Reidy, Namrata Vijayvergia, Daniel M Halperin, Grace Goldstein, Grace Kong, Michael Michael, Simone Leyden, Simona Grozinsky-Glasberg, Halfdan Sorbye, Kjell E Oberg, Cristina Sierras, Philip Harris

Conference Proceedings  |  2022  |  JOURNAL OF CLINICAL ONCOLOGY

TPS514 Background: Gastroenteropancreatic neuroendocrine tumors (GEP-NETs), which represent approximately 70% of NETs, frequently..

Incidence, prevalence, and survival trends for neuroendocrine neoplasms in Victoria, Australia, from 1982 to 2019: Based on site, grade, and region

M Michael, V Thursfield, L te Marvelde, G Kong, RJ Hicks

Journal article  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

AIMS: Neuroendorcine neoplasms (NENs) are rare tumors characterised by variable biology and delayed diagnosis. Several population ..

Optimal PLAnning of treatment and research of neuroendocrine tumours (NETs) in Australia: The PLANET registry and patient-reported outcomes via PLANET App

Meredith Cummins, Simone Leyden, Nick Pavlakis, David Chan, Michael Michael, Rod Hicks, Grace Kong, Annette Hogg, Timothy Price, Gabrielle Cehic, David Ransom, Richard Sinnott, Anthony Stell

Conference Proceedings  |  2021  |  ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY

PRINCE: Interim analysis of the phase Ib study of Lu-177-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)

SK Sandhu, AM Joshua, L Emmett, L Spain, LG Horvath, M Crumbaker, A Anton, R Wallace, A Pasam, M Bressel, E Cassidy, P Banks, AR Kumar, R Alipour, T Akhurst, G Kong, ID Davis, S Williams, R Hicks, M Hofman

Conference Proceedings  |  2021  |  ANNALS OF ONCOLOGY

Radionuclide imaging of NENs

G Kong, R Hicks

Journal article  |  2021  |  Current Opinion in Endocrine and Metabolic Research

Neuroendocrine neoplasms (NENs) represent a heterogeneous group of tumours. CT or MRI, while being widely available, have recognis..

PEPTIDE RECEPTOR RADIONUCLIDE THERAPY IN LUNG CARCINOIDS: A BICENTER STUDY

L Zidan, A Iravani, K Oleinikov, S Ben-Haim, DJ Gross, A Meirovitz, O Maimon, T Akhurst, M Michael, RJ Hicks, S Grozinsky-Glasberg, G Kong

Conference Proceedings  |  2021  |  INTERNAL MEDICINE JOURNAL

Prognostic biomarkers in men with metastatic castration-resistant prostate cancer receiving [177Lu]-PSMA-617

Justin Ferdinandus, John Violet, Shahneen Sandhu, Rodney J Hicks, Aravind S Ravi Kumar, Amir Iravani, Grace Kong, Tim Akhurst, Sue Ping Thang, Declan G Murphy, Scott Williams, Michael S Hofman

Journal article  |  2020  |  EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING

PURPOSE: We analysed quantitative biomarkers derived from both baseline whole-body imaging and blood serum to identify prognostic ..